お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は筋骨格系疾患治療薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは筋骨格系疾患治療薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の筋骨格系疾患治療薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは筋骨格系疾患治療薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に筋骨格系疾患治療薬市場を分類しています。本研究に含まれる主な企業は：AbbVie、Johnson & Johnson、Amgen、Pfizer、F. Hoffmann-La Roche、Eli Lilly、Merck、Novartis、AstraZeneca、Astellas、AB Sciences、3SBio、Samsung Bioepis、Sanofi、Taisho Pharmaceutical、Takeda、Zosano Pharma、LG Life Sciences

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Biologics
    Small Molecules

用途別の市場セグメント：
    Osteoarthritis
    Osteoporosis
    Psoriatic Arthritis
    Ankylosing Spondylitis
    Fibromyalgia

本レポートの詳細内容
世界の筋骨格系疾患治療薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、筋骨格系疾患治療薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の筋骨格系疾患治療薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の筋骨格系疾患治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、筋骨格系疾患治療薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

筋骨格系疾患治療薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：筋骨格系疾患治療薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：筋骨格系疾患治療薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章筋骨格系疾患治療薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：筋骨格系疾患治療薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：筋骨格系疾患治療薬の主要企業の概要を提供し、製品の説明と仕様、筋骨格系疾患治療薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Musculoskeletal Disorders Therapeutics Market
The global Musculoskeletal Disorders Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Musculoskeletal Disorders Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Musculoskeletal Disorders Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Musculoskeletal Disorders Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Musculoskeletal Disorders Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Musculoskeletal Disorders Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Musculoskeletal Disorders Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    AbbVie
    Johnson & Johnson
    Amgen
    Pfizer
    F. Hoffmann-La Roche
    Eli Lilly
    Merck
    Novartis
    AstraZeneca
    Astellas
    AB Sciences
    3SBio
    Samsung Bioepis
    Sanofi
    Taisho Pharmaceutical
    Takeda
    Zosano Pharma
    LG Life Sciences

Segment by Type
    Biologics
    Small Molecules

Segment by Application
    Osteoarthritis
    Osteoporosis
    Psoriatic Arthritis
    Ankylosing Spondylitis
    Fibromyalgia

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Musculoskeletal Disorders Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal Disorders Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Musculoskeletal Disorders Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Biologics
    Table 3. Key Players of Small Molecules
    Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2025-2030)
    Table 10. Musculoskeletal Disorders Therapeutics Market Trends
    Table 11. Musculoskeletal Disorders Therapeutics Market Drivers
    Table 12. Musculoskeletal Disorders Therapeutics Market Challenges
    Table 13. Musculoskeletal Disorders Therapeutics Market Restraints
    Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Musculoskeletal Disorders Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Musculoskeletal Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)
    Table 17. Global Musculoskeletal Disorders Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Musculoskeletal Disorders Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Musculoskeletal Disorders Therapeutics, Product and Application
    Table 21. Global Key Players of Musculoskeletal Disorders Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Musculoskeletal Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Musculoskeletal Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Musculoskeletal Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Musculoskeletal Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Musculoskeletal Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Musculoskeletal Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Musculoskeletal Disorders Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Musculoskeletal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Musculoskeletal Disorders Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Musculoskeletal Disorders Therapeutics Product
    Table 66. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. Johnson & Johnson Company Details
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product
    Table 71. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Johnson & Johnson Recent Developments
    Table 73. Amgen Company Details
    Table 74. Amgen Business Overview
    Table 75. Amgen Musculoskeletal Disorders Therapeutics Product
    Table 76. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Amgen Recent Developments
    Table 78. Pfizer Company Details
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Musculoskeletal Disorders Therapeutics Product
    Table 81. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Pfizer Recent Developments
    Table 83. F. Hoffmann-La Roche Company Details
    Table 84. F. Hoffmann-La Roche Business Overview
    Table 85. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product
    Table 86. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. F. Hoffmann-La Roche Recent Developments
    Table 88. Eli Lilly Company Details
    Table 89. Eli Lilly Business Overview
    Table 90. Eli Lilly Musculoskeletal Disorders Therapeutics Product
    Table 91. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. Eli Lilly Recent Developments
    Table 93. Merck Company Details
    Table 94. Merck Business Overview
    Table 95. Merck Musculoskeletal Disorders Therapeutics Product
    Table 96. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Merck Recent Developments
    Table 98. Novartis Company Details
    Table 99. Novartis Business Overview
    Table 100. Novartis Musculoskeletal Disorders Therapeutics Product
    Table 101. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. Novartis Recent Developments
    Table 103. AstraZeneca Company Details
    Table 104. AstraZeneca Business Overview
    Table 105. AstraZeneca Musculoskeletal Disorders Therapeutics Product
    Table 106. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. AstraZeneca Recent Developments
    Table 108. Astellas Company Details
    Table 109. Astellas Business Overview
    Table 110. Astellas Musculoskeletal Disorders Therapeutics Product
    Table 111. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 112. Astellas Recent Developments
    Table 113. AB Sciences Company Details
    Table 114. AB Sciences Business Overview
    Table 115. AB Sciences Musculoskeletal Disorders Therapeutics Product
    Table 116. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 117. AB Sciences Recent Developments
    Table 118. 3SBio Company Details
    Table 119. 3SBio Business Overview
    Table 120. 3SBio Musculoskeletal Disorders Therapeutics Product
    Table 121. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 122. 3SBio Recent Developments
    Table 123. Samsung Bioepis Company Details
    Table 124. Samsung Bioepis Business Overview
    Table 125. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product
    Table 126. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 127. Samsung Bioepis Recent Developments
    Table 128. Sanofi Company Details
    Table 129. Sanofi Business Overview
    Table 130. Sanofi Musculoskeletal Disorders Therapeutics Product
    Table 131. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 132. Sanofi Recent Developments
    Table 133. Taisho Pharmaceutical Company Details
    Table 134. Taisho Pharmaceutical Business Overview
    Table 135. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product
    Table 136. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 137. Taisho Pharmaceutical Recent Developments
    Table 138. Takeda Company Details
    Table 139. Takeda Business Overview
    Table 140. Takeda Musculoskeletal Disorders Therapeutics Product
    Table 141. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 142. Takeda Recent Developments
    Table 143. Zosano Pharma Company Details
    Table 144. Zosano Pharma Business Overview
    Table 145. Zosano Pharma Musculoskeletal Disorders Therapeutics Product
    Table 146. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 147. Zosano Pharma Recent Developments
    Table 148. LG Life Sciences Company Details
    Table 149. LG Life Sciences Business Overview
    Table 150. LG Life Sciences Musculoskeletal Disorders Therapeutics Product
    Table 151. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 152. LG Life Sciences Recent Developments
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Biologics Features
    Figure 4. Small Molecules Features
    Figure 5. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Osteoarthritis Case Studies
    Figure 8. Osteoporosis Case Studies
    Figure 9. Psoriatic Arthritis Case Studies
    Figure 10. Ankylosing Spondylitis Case Studies
    Figure 11. Fibromyalgia Case Studies
    Figure 12. Musculoskeletal Disorders Therapeutics Report Years Considered
    Figure 13. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Musculoskeletal Disorders Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Musculoskeletal Disorders Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2023
    Figure 19. North America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Musculoskeletal Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Musculoskeletal Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Musculoskeletal Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Musculoskeletal Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Musculoskeletal Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Musculoskeletal Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Musculoskeletal Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Musculoskeletal Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Musculoskeletal Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Musculoskeletal Disorders Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 60. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 61. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 63. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 66. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 67. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 68. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 69. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 70. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 71. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 72. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 73. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 74. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 75. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed